ELTX Insider Trading Activity and SEC Form 4 Filings
ELTX insider trading summary
No open-market insider purchases or sales of Elicio Therapeutics, Inc. (ELTX) have been reported on SEC Form 4 in the past 12 months.
Latest ELTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 22, 2023 | Gkcc, LLC | 10% Owner | Buy | $7.0M (1,213,000 @ $5.81) |
| Dec 22, 2023 | Yekaterina Chudnovsky | Director | Buy | $7.0M (1,213,000 @ $5.81) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.